Stimuli responsive nanosonosensitizers for sonodynamic therapy
Journal of Controlled Release · 2023-09 · 361 · 547-567
DOI: 10.1016/j.jconrel.2023.08.003 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Controlled Release, 2023-09. Verfasst von Zeyu Jiang und 2 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Translational Medicine, The Affiliated Hospital of Qingdao University, College of Medicine, Qingdao University, Qingdao 266021, China; …. Hauptthemen laut MEDLINE: Ultrasonic Therapy, Neoplasms. Die Arbeit wurde bisher 176-mal zitiert (Crossref) und nennt 173 Literaturangaben.
Abstract (Originalsprache)
Sonodynamic therapy (SDT) has gained significant attention in the treatment of deep tumors and multidrug-resistant (MDR) bacterial infections due to its high tissue penetration depth, high spatiotemporal selectivity, and noninvasive therapeutic method. SDT combines low-intensity ultrasound (US) and sonosensitizers to produce lethal reactive oxygen species (ROS) and external damage, which is the main mechanism behind this therapy. However, traditional organic small-molecule sonosensitizers display poor water solubility, strong phototoxicity, and insufficient targeting ability. Inorganic sonosensitizers, on the other hand, have low ROS yield and poor biocompatibility. These drawbacks have hindered SDT's clinical transformation and application. Hence, designing stimuli-responsive nano-sonosensitizers that make use of the lesion's local microenvironment characteristics and US stimulation is an excellent alternative for achieving efficient, specific, and safe treatment. In this review, we provide a comprehensive overview of the currently accepted mechanisms in SDT and discuss the application of responsive nano-sonosensitizers in the treatment of tumor and bacterial infections. Additionally, we emphasize the significance of the principle and process of response, based on the classification of response patterns. Finally, this review emphasizes the potential limitations and future perspectives of SDT that need to be addressed to promote its clinical transformation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute for Translational Medicine, The Affiliated Hospital of Qingdao University, College of Medicine, Qingdao University, Qingdao 266021, China; Department of Cardiovascular Medicine, The Affiliated Hospital of Qing…
- Department of Radiotherapy, The Affiliated Hospital of Qingdao University, College of Medicine, Qingdao University, Qingdao 266021, China.
- Institute for Translational Medicine, The Affiliated Hospital of Qingdao University, College of Medicine, Qingdao University, Qingdao 266021, China. Electronic address: fuqinrui2022@qdu.edu.cn.
Zitieren
APA
Jiang, Z., Xiao, W., & Fu, Q. (2023). Stimuli responsive nanosonosensitizers for sonodynamic therapy. Journal of Controlled Release, 361, 547-567. https://doi.org/10.1016/j.jconrel.2023.08.003
Vancouver
Jiang Z, Xiao W, Fu Q. Stimuli responsive nanosonosensitizers for sonodynamic therapy. Journal of Controlled Release. 2023;361:547-567. doi:10.1016/j.jconrel.2023.08.003
BibTeX
@article{Jiang2023,
author = {Jiang, Zeyu and Xiao, Wenjing and Fu, Qinrui},
title = {Stimuli responsive nanosonosensitizers for sonodynamic therapy},
journal = {Journal of Controlled Release},
year = {2023},
volume = {361},
pages = {547--567},
doi = {10.1016/j.jconrel.2023.08.003}
}
EUVIMED